Investor interest has focused on companies nearing key milestones, signing major partnerships, or improving their business ...

Is SLS a good stock to buy? We came across a bullish thesis on SELLAS Life Sciences Group, Inc. on BioEquity Watch’s Substack ...

Companies say the acquisition will accelerate growth with investment and an AI-enabled platform focused on curated ...

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

Vancouver-based cancer drug maker Zymeworks Inc. ZYME-Q is buying Theravance Biopharma Inc. for US$929-million in cash with ...

Anterra Capital has raised $100 million so far to invest in the next generation of technology companies with practical ...

The bond money would be split to fund an immunology and immunotherapy research institute affiliated with the University of ...

Hercules Capital maintains strong credit quality, with only 0.1% of its portfolio on non-accrual and a 12% yield. Read why ...

Just when you thought Delta's footprint at Hartsfield-Jackson couldn't get any larger, the Atlanta-based airline has made a ...

Acquisition adds YUPELRI ® (revefenacin), the first and only approved nebulized long-acting muscarinic antagonist (LAMA) for the maintenance treatment of COPD to Zymeworks' portfolio Acquisition of ...

Obesity in the Margin War Eli Lilly and Novo Nordisk are locked in a fierce battle for market share in the ...

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.